Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era

Diagnostic Microbiology and Infectious Disease

Volumn 57, Issue 3 SUPPL., 2007, Pages

  Owens Jr , Robert C ^a,b   Ambrose, Paul G ^c  

^a MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

Antimicrobial stewardship; Cephalosporins; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFIXIME; CEFPROZIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; DAPTOMYCIN; DOXYCYCLINE; LINEZOLID; METRONIDAZOLE; MONOBACTAM DERIVATIVE; ORITAVANCIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TELITHROMYCIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; ARTICLE; DRUG USE; HUMAN; INFECTION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES;

EID: 33847376814     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.12.012     Document Type: Article

References (48)

1. Ambrose P.G., Grasela D.M., Grasela T.H., Passarell J., Mayer H.B., and Pierce P.F. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob. Agents Chemother. 45 (2001) 2793-2797
2. Bell D.M. Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention. Clin. Infect. Dis. 33 Suppl 3 (2001) S245-S250
3. Craig W.A. Pharmacodynamics of antimicrobials: general concepts and applications. In: Nightingale C.H., Murakawa T., and Ambrose P.G. (Eds). Antimicrobial Pharmacodynamics in Theory and Practice. 1st ed. (2002), Marcel Dekker, New York 1-22
4. Craig W.A., and Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15 (1996) 255-259
5. Davey P., Brown E., Fenelon L., Finch R., Gould I., Hartman G., Holmes A., Ramsay C., Taylor E., Wilcox M., and Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (Online) (2005) CD003543
6. Davey P., Brown E., Fenelon L., Finch R., Gould I., Holmes A., Ramsay C., Taylor E., Wiffen P., and Wilcox M. Systematic review of antimicrobial drug prescribing in hospitals. Emerg. Infect. Dis. 12 (2006) 211-216
7. Dellit T.H., Owens Jr. R.C., McGowan Jr. J.E., Gerding D.N., Weinstein R.A., Huskins W.C., Peterson D.L., Fishman N.O., Carpenter C., Brennan P.J., Billeter M., and Hooton T.M. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44 (2007) 159-177
8. Dowell S.F. Otitis media. In: Nightingale C.H., and Ambrose P.G. (Eds). Community-Acquired Respiratory Tract Infections: Antimicrobial Management (2003), Marcel Dekker, New York 181-200
9. Eagle H., Fleischman R., and Musselman A.D. Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels. Am. J. Med. 9 (1950) 280-299
10. Eagle H., Fleischman R., and Musselman A.D. The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum. J. Bacteriol. 59 (1950) 625-643
11. Eagle H., Fleischman R., and Levy M. "Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy. N. Engl. J. Med. 248 (1953) 481-488
12. Eden T., Anari M., Ernstson S., and Sundberg L. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media. Scand. J. Infect. Dis. Suppl. 39 (1983) 48-52
13. Forrest A., Nix D.E., Ballow C.H., Goss T.F., Birmingham M.C., and Schentag J.J. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37 (1993) 1073-1081
14. Glowacki R.C., Schwartz D.N., Itokazu G.S., Wisniewski M.F., Kieszkowski P., and Weinstein R.A. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin. Infect. Dis. 37 (2003) 59-64
15. Greco P.J., and Eisenberg J.M. Changing physicians' practices. N. Engl. J. Med. 329 (1993) 1271-1273
16. Kiang K.M., Kieke B.A., Como-Sabetti K., Lynfield R., Besser R.E., and Belongia E.A. Clinician knowledge and beliefs after statewide program to promote appropriate antimicrobial drug use. Emerg. Infect. Dis. 11 (2005) 904-911
17. Krause P.J., Owens N.J., Nightingale C.H., Klimek J.J., Lehmann W.B., and Quintiliani R. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J. Infect. Dis. 145 (1982) 815-821
18. Kunin C.M. Antibiotic armageddon. Clin. Infect. Dis. 25 (1997) 240-241
19. Levy S.B., FitzGerald G.B., and Macone A.B. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N. Engl. J. Med. 295 (1976) 583-588
20. Lodise T.P., Preston S., Bhargava V., Bryskier A., Nusrat R., Chapel S., Rangaraju M., and Drusano G.L. Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens. Diagn. Microbiol. Infect. Dis. 52 (2005) 45-52
21. McCaig L.F., Besser R.E., and Hughes J.M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287 (2002) 3096-3102
22. McDonald L.C., Killgore G.E., Thompson A., Owens Jr. R.C., Kazakova S.V., Sambol S.P., Johnson S., and Gerding D.N. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353 (2005) 2433-2441
23. McGowan Jr. J.E. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?. Infect. Control. Hosp. Epidemiol. 15 (1994) 478-483
24. Moberg C.L. Rene Dubos: a harbinger of microbial resistance to antibiotics. Microb. Drug Resist. 2 (1996) 287-297
25. Owens Jr. R.C. QT prolongation with antimicrobial agents: understanding the significance. Drugs 64 (2004) 1091-1124
26. Owens R.C. Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 26 (2006) 299-311
27. Owens Jr. R.C., and Ambrose P.G. Antimicrobial safety: focus on fluoroquinolones. Clin. Infect. Dis. 41 Suppl 2 (2005) S144-S157
28. Owens Jr. R.C., and Rice L. Hospital-based strategies for combating resistance. Clin. Infect. Dis. 42 Suppl 4 (2006) S173-S181
29. Owens Jr. R.C., Fraser G.L., and Stogsdill P. Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 24 (2004) 896-908
30. Palmer D.A., and Bauchner H. Parents' and physicians' views on antibiotics. Pediatrics 99 (1997) E6
31. Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., Pepin K., and Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003 A changing pattern of disease severity. CMAJ 171 (2004) 466-472
32. Pepin J., Routhier S., Gagnon S., and Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin. Infect. Dis. 42 (2006) 758-764
33. Pottumarthy S., Fritsche T.R., and Jones R.N. Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003). Diagn. Microbiol. Infect. Dis. 51 (2005) 147-150
34. Preston S.L., Drusano G.L., Berman A.L., Fowler C.L., Chow A.T., Dornseif B., Reichl V., Natarajan J., and Corrado M. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279 (1998) 125-129
35. Projan S.J. Why is big Pharma getting out of antibacterial drug discovery?. Curr. Opin. Microbiol. 6 (2003) 427-430
36. Razon Y., Ashkenazi S., Cohen A., Hering E., Amzel S., Babilsky H., Bahir A., Gazala E., and Levy I. Effect of educational intervention on antibiotic prescription practices for upper respiratory infections in children: a multicentre study. J. Antimicrob. Chemother. 56 (2005) 937-940
37. Rosenfeld R.M., Culpepper L., Doyle K.J., Grundfast K.M., Hoberman A., Kenna M.A., Lieberthal A.S., Mahoney M., Wahl R.A., Woods Jr. C.R., and Yawn B. Clinical practice guideline: otitis media with effusion. Otolaryngol. Head Neck Surg. 130 (2004) S95-S118
38. Rubin M.A., Bateman K., Alder S., Donnelly S., Stoddard G.J., and Samore M.H. A multifaceted intervention to improve antimicrobial prescribing for upper respiratory tract infections in a small rural community. Clin. Infect. Dis. 40 (2005) 546-553
39. Sader H.S., Fritsche T.R., Mutnick A.H., and Jones R.N. Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002). Diagn. Microbiol. Infect. Dis. 47 (2003) 515-525
40. Samore M.H., Bateman K., Alder S.C., Hannah E., Donnelly S., Stoddard G.J., Haddadin B., Rubin M.A., Williamson J., Stults B., Rupper R., and Stevenson K. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA 294 (2005) 2305-2314
41. Sarkar P., and Gould I.M. Antimicrobial agents are societal drugs: how should this influence prescribing?. Drugs 66 (2006) 893-901
42. Scaglione F., Demartini G., Dugnani S., Arcidiacono M.M., Pintucci J.P., and Fraschini F. Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. Br. J. Clin. Pharmacol. 47 (1999) 267-271
43. Schiff G.D., Wisniewski M., Bult J., Parada J.P., Aggarwal H., and Schwartz D.N. Improving inpatient antibiotic prescribing: insights from participation in a national collaborative. Jt. Comm. J. Qual. Improv. 27 (2001) 387-402
44. Shah P.M., and Stille W. Bactericidal dose-activity relationships with E. coli, K. pneumoniae and S. aureus. (author's translation). Dtsch. Med. Wochenschr. 101 (1976) 325-328
45. Shyu W.C., Haddad J., Reilly J., Khan W.N., Campbell D.A., Tsai Y., and Barbhaiya R.H. Penetration of cefprozil into middle ear fluid of patients with otitis media. Antimicrob. Agents Chemother. 38 (1994) 2210-2212
46. Soumerai S.B., and Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 263 (1990) 549-556
47. Watson R.L., Dowell S.F., Jayaraman M., Keyserling H., Kolczak M., and Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics 104 (1999) 1251-1257
48. Wenzel R.P., and Edmond M.B. Managing antibiotic resistance. N. Engl. J. Med. 343 (2000) 1961-1963